Stockscreener 앱 받기
10.00
3.41%
0.33
전일 마감가:
$9.67
열려 있는:
$9.97
하루 거래량:
1,856
Relative Volume:
0.22
시가총액:
$58.38M
수익:
$503.40K
순이익/손실:
$9.17M
주가수익비율:
5.5221
EPS:
1.8109
순현금흐름:
$-604.40K
1주 성능:
+0.00%
1개월 성능:
-6.98%
6개월 성능:
-18.77%
1년 성능:
+11.11%
1일 변동 폭
$9.97
$10.07
1주일 범위
$9.26
$10.28
52주 변동 폭
$8.56
$14.76
Daxor Corporation Stock (DXR) Company Profile
명칭
Daxor Corporation
전화
212-330-8500
주소
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
10.00 | 56.46M | 503.40K | 9.17M | -604.40K | 1.8109 |
ISRG
Intuitive Surgical Inc
|
417.07 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.16 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.84 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.09 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
193.94 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-05-16 | 개시 | Ascendiant Capital Markets | Buy |
Daxor Corporation 주식(DXR)의 최신 뉴스
Behavioral Patterns of DXR and Institutional Flows - Stock Traders Daily
Daxor Corporation (DXR) Declines 4.39%: Approaching Key Support Near $10.07PCR Moving Average - newsline.com
Daxor Corporation (DXR) Q3 2007 Earnings: EPS Surges 325% Above Estimates, Stock Declines Despite BeatRevenue Breakdown Analysis - newsline.com
Daxor (DXR) plans June 23, 2026 vote on directors and auditor - Stock Titan
Daxor (DXR) Secures Patent for Innovative Blood Volume Monitorin - GuruFocus
New patent links smartwatches to blood volume tracking for heart failure - Stock Titan
DXR - Finviz
Daxor Corporation (DXR) Surges 4.1%: Testing Resistance After Strong Intraday MomentumHagopian Line - newsline.com
(DXR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
DXR Q3 2007 Earnings: Earnings Per Share Surges Past EstimatesEarnings Miss Alert - newsline.com
Daxor Corporation (DXR) Holds Steady at $10.82 as Shares Test Key Support ZoneOpen Trading Community - Newser
DXR Q3 2007 Earnings: Significant Earnings Beat Driven by Strong Operational PerformanceEarnings Sentiment Score - Newser
Daxor Corporation (DXR) Q3 2007 Earnings: Landmark EPS Beat Lifts Sentiment Despite No Revenue DisclosureSocial Signal Watchlist - Newser
Number of shareholders of Daxor Corporation – FWB:DX5 - TradingView
DXR Daxor Q3 results shatter estimates with 3257 EPS surprise 3835 revenue surge driving 3 stock gainCommunity Sell Signals - Newser
How (DXR) Movements Inform Risk Allocation Models - Stock Traders Daily
TradingKey - TradingKey
Daxor (DXR) reports quarterly earnings as company outlines strategic priorities amid market uncertainty.Social Signal Watchlist - Newser
The long term thesis for Daxor (DXR) in plain sight (-4.73%) 2026-05-08Profit Surge Picks - newsline.com
Trading Systems Reacting to (DXR) Volatility - Stock Traders Daily
What Daxor (DXR) is doing that could pay off big later (Climbs) 2026-05-05Investment Community Signals - newser.com
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis - The Globe and Mail
5,061,267 Common Stock of Daxor Corporation are subject to a Lock-Up Agreement Ending on 27-APR-2026. - marketscreener.com
How Daxor Corporation (DXR) Affects Rotational Strategy Timing - Stock Traders Daily
(DXR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
RSI Check: What is the long term forecast for Daxor Corporation stockEarnings Miss & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
CEO Moves: Is Daxor Corporation stock risky to hold now2026 Drop Watch & Consistent Profit Trading Strategies - baoquankhu1.vn
Insider Buying: Michael Feldschuh Acquires Additional Shares of Daxor Corp (DXR) - GuruFocus
Daxor CEO Feldschuh buys $9,070 in shares By Investing.com - Investing.com South Africa
Daxor CEO Feldschuh buys $9,070 in shares - Investing.com
DAXOR (DXR) CEO Michael Feldschuh adds 1,000 shares in open-market buy - Stock Titan
Daxor launches blood volume testing program in Ohio By Investing.com - Investing.com South Africa
Daxor Corporation Expands Customer Footprint With New BVA Program At High-Volume Ohio Cardiology Center - marketscreener.com
Daxor launches blood volume testing program in Ohio - Investing.com
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center - GlobeNewswire
Income Plays: Is Daxor Corporation vulnerable to short sellers2026 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
Can Daxor (DXR) Stock Double in 2026 | Price at $9.16, Down 5.52%IPO Entry Watch - newsline.com
[N-CEN/A] DAXOR CORP SEC Filing - Stock Titan
Insider Buying: Robert Michel Acquires Shares of Daxor Corp (DXR) - GuruFocus
Michel, Daxor CFO, buys $9,900 in DXR stock - Investing.com
Michel, Daxor CFO, buys $9,900 in DXR stock By Investing.com - Investing.com India
DAXOR CORP (DXR) CFO adds 1,000 shares in open-market buy - Stock Titan
DXR PE Ratio & Valuation, Is DXR Overvalued - Intellectia AI
Setup Watch: Will Daxor Corporation stock go up in YEARNew Guidance & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Earnings Risk: What is the target price for Daxor Corporation stock2026 Biggest Moves & High Accuracy Trade Alerts - baoquankhu1.vn
Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026 - Bitget
Daxor’s Blood Volume Analysis Metric Validated as Uniquely - GlobeNewswire
Common leak scores stayed low while Daxor measured 20% hourly leak - Stock Titan
Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat
Daxor Corporation (DXR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.68%
0.71%
자본화:
|
볼륨(24시간):